
Corporate
Cardinal Health Raises FY26 Guidance Above Consensus as Specialty Pharma Surges
Jan 13
You're signed outSign in or to get full access.
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
Research analysts covering CARDINAL HEALTH.